Thomas B. King

Insider Reports History

Entity
Individual
Location
91 James Avenue, Atherton, CA
Signature
/s/ Thomas B. King
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas B. King:

Stock Role Class Num Shares Value Price $ Report Date Ownership
TFF Pharmaceuticals, Inc. Director Restricted stock units 3.11K $1.22K $0.39 Apr 18, 2024 Direct
TFF Pharmaceuticals, Inc. Director Common Stock 1.58K $620 $0.39 Jul 3, 2024 Direct
ACHIEVE LIFE SCIENCES, INC. Director Stock Option (right to buy) 31.5K Jan 22, 2024 Direct
TFF Pharmaceuticals, Inc. Director Stock Options (Right to Buy) 1.58K Jul 3, 2024 Direct
Satsuma Pharmaceuticals, Inc. Director Stock Option (right to buy) 0 Jun 8, 2023 Direct

Insider Reports Filed by Thomas B. King

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TFFP TFF Pharmaceuticals, Inc. Jul 3, 2024 2 $0 4 Jul 8, 2024 Director
TFFP TFF Pharmaceuticals, Inc. Apr 18, 2024 1 $0 4 Apr 22, 2024 Director
ACHV ACHIEVE LIFE SCIENCES, INC. Jan 22, 2024 1 $0 4 Jan 24, 2024 Director
TFFP TFF Pharmaceuticals, Inc. Dec 13, 2023 1 $0 4 Dec 15, 2023 Director
TFFP TFF Pharmaceuticals, Inc. Dec 11, 2023 0 $0 3 Dec 15, 2023 Director
STSA Satsuma Pharmaceuticals, Inc. Jun 8, 2023 6 $0 4 Jun 8, 2023 Director
ACHV ACHIEVE LIFE SCIENCES, INC. Mar 29, 2023 1 $0 4 Jun 9, 2023 Director
ACHV ACHIEVE LIFE SCIENCES, INC. Mar 29, 2023 1 $0 4 Mar 30, 2023 Director
ACHV ACHIEVE LIFE SCIENCES, INC. Mar 29, 2023 0 $0 3 Mar 30, 2023 Director
STSA Satsuma Pharmaceuticals, Inc. Jun 3, 2022 1 $0 4 Jun 7, 2022 Director